Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update
- Forfatter(e)
- Fischer, H. S. Reibel, N. J. Buhrer, C. Dame, C.
- År
- 2021
- Tidsskrift
- FRONTIERS IN PEDIATRICS
- Sider
- 657228
- Kategori(er)
- Kognisjon (hukommelse, oppmerksomhet og eksekutive funksjoner) Språk og motorikkFor tidlig fødsel
- Tiltakstype(r)
- Abstract
A meta-analysis update of randomized controlled trials investigating recombinant human erythropoietin suggests improved neurodevelopmental outcome in preterm infants. There was substantial heterogeneity, which could be ascribed to a single trial. Exclusion of this trial featuring a high risk of bias abolished heterogeneity and any effects of recombinant human erythropoietin treatment.